As the Obama Administration and the 111th Congress prepare to reform health care, join us for a briefing and round table discussion of what might be done to ensure that comparative effectiveness is implemented in a manner that protects innovation.
Principals and staff from National Health Advisors (NHA) will offer insights into the framework for the debate, the Congressional agenda, potential positions and communication strategies in Congress and the federal regulatory agencies.
WHO SHOULD ATTEND?
Private Equity Sponsors of companies in the Medical Device, Biotechnology, and Pharmaceutical sectors, as well as representatives from their portfolio companies.
Briefings will include perspectives from the following NHA personnel:
Comparative Effectiveness in Current Coverage,
Coding and Payment Policies Public and Private
Former Acting Administrator – Centers for Medicare and Medicaid, EBG Advisors/NHA
Oldaker, Belair & Wittie, LLP/NHA
What Constitutes Evidence — and How Can it be Measured?
Joel Brill, MD
There is no fee to attend this event.
Please RSVP no later than January 19, 2009.
at 202.861- 1872, or firstname.lastname@example.org.